Click the title above for a link to open the Pharmaceutical Executive May 2024 issue in an interactive PDF format.
Pharmaceutical Executive: May 2024
This month, we spotlight the inspiring story of the Healthcare Businesswomen’s Association Woman of the Year, Yvonne Greenstreet.
Industry experts, in a roundtable discussion, explore the evolution of brand engagement in the age of AI, including the growing importance of message relevance—and, for pharma, going where the information is.
Designing an effective travel and lodging patient hub program in pharma.
With competition for follow-on-biologics on the upswing—and a potential market boom perhaps around the corner—continued education and course-setting for all stakeholders in charting the access landscape is paramount.
A greater shift from paper records and physical assets is achievable.
Now-unclear timing on rate cuts puts onus back on fundamentals.
From Big Pharma to biotech—and a globe-spanning journey along the way—Yvonne Greenstreet, this year’s Healthcare Businesswomen’s Association Woman of the Year, is right where she wants to be: leading efforts to advance “bold ideas” in RNAi therapeutics into life-changing gains for patients.
Insight that can help smaller biotech companies prepare for commercialization in the world of big pharma.
